Risk factors for, and molecular epidemiology and clinical outcomes of, carbapenem‐ and polymyxin‐resistant Gram‐negative bacterial infections in pregnant women, infants, and toddlers: a systematic review and meta‐analyses
- 2 July 2021
- journal article
- review article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 1502 (1) , 54-71
Abstract
In the following systematic review and meta‐analyses, we report several conclusions about resistance to carbapenem and polymyxin last‐resort antibiotics for treating multidrug‐resistant bacterial infections among pregnant women and infants. Resistance to carbapenems and polymyxins is increasing, even in otherwise vulnerable groups such as pregnant women, toddlers, and infants, for whom therapeutic options are limited. In almost all countries, carbapenem‐/polymyxin–resistant Klebsiella pneumoniae, Escherichia coli, and Acinetobacter baumannii infect and/or colonize neonates and pregnant women, causing periodic outbreaks with very high infant mortalities. Downregulation of plasmid‐borne blaNDM, blaKPC, blaOXA‐48, blaIMP, blaVIM, blaGES‐5, and ompK35/36 in clonal strains accelerates the horizontal and vertical transmissions of carbapenem resistance among these pathogens. New Delhi metallo‐β‐lactamase (NDM)–positive isolates in infants/neonates have been mainly detected in China and India, while OXA‐48–positive isolates in infants/neonates have been mainly detected in Africa. NDM‐positive isolates in pregnant women have been found only in Madagascar. Antibiotic therapy, prolonged hospitalization, invasive procedures, mechanical ventilation, low birth weight, and preterm delivery have been common risk factors associated with carbapenem/polymyxin resistance. The use of polymyxins to treat carbapenem‐resistant infections may be selecting for resistance to both agents, restricting therapeutic options for infected infants and pregnant women. Currently, low‐ and middle‐income countries have the highest burden of these pathogens. Antibiotic stewardship, periodic rectal and vaginal screening, and strict infection control practices in neonatal ICUs are necessary to forestall future outbreaks and deaths.Keywords
All Related Versions
This publication has 84 references indexed in Scilit:
- Community acquisition of β-lactamase producing Enterobacteriaceae in neonatal gutBMC Microbiology, 2013
- Acquisition of carbapenem resistance in multiresistant Klebsiella pneumoniae isolates of sequence type 11 at a university hospital in ChinaDiagnostic Microbiology and Infectious Disease, 2013
- Occurrence and characterization of multidrug-resistant New Delhi metallo-β-lactamase-1-producing bacteria isolated between 2003 and 2010 in BangladeshJournal of Medical Microbiology, 2013
- The emergence of multidrug-resistantKlebsiella pneumoniaeof international clones ST13, ST16, ST35, ST48 and ST101 in a teaching hospital in the Paris regionEpidemiology and Infection, 2012
- Identification of a plasmid-borne bla IMP-11 gene in clinical isolates of Escherichia coli and Klebsiella pneumoniaeJournal of Medical Microbiology, 2012
- Transmission of imipenem resistance determinants during the course of an outbreak of NDM-1 Escherichia coli in a sick newborn care unitJournal of Antimicrobial Chemotherapy, 2011
- A novel VIM‐type metallo‐beta‐lactamase (VIM‐14) in a Pseudomonas aeruginosa clinical isolate from a neonatal intensive care unitClinical Microbiology and Infection, 2011
- Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological studyThe Lancet Infectious Diseases, 2010
- Etiology of neonatal blood stream infections in Tbilisi, Republic of GeorgiaInternational Journal of Infectious Diseases, 2009
- Nosocomial colonization due to imipenem-resistant Pseudomonas aeruginosa epidemiologically linked to breast milk feeding in a neonatal intensive care unitActa Pharmacologica Sinica, 2008